D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ABUS holding history
Arbutus Biopharma Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings
- Shares (Q2 2026)
- 381,863
- Value
- $1.83M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 381,863 | $1.83M | <0.1% | +238,662+166.7% | Added | Holders |
| Q1 2026 | 143,201 | $644.4K | <0.1% | −88,562−38.2% | Reduced | Holders |
| Q4 2025 | 231,763 | $1.11M | <0.1% | +41,811+22.0% | Added | Holders |
| Q3 2025 | 189,952 | $862.4K | <0.1% | +149,252+366.7% | Added | Holders |
| Q2 2025 | 40,700 | $125.8K | <0.1% | +40,700 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −19,698−100.0% | Sold out | Holders |
| Q1 2022 | 19,698 | $59.0K | <0.1% | −3,202−14.0% | Reduced | Holders |
| Q4 2021 | 22,900 | $89.0K | <0.1% | +22,900 | New | Holders |